A nanotechnology-based anticancer drug has been launched in India by Biocon India and Abraxis BioScience CA, USA.

FDA will establish eight full-time positions at the US Diplomatic posts in China.

Japanese approval for advanced treatments

The catch-up game; Generics central

Asia is not a homogenous landscape. It is made up of countries with different cultures, practices and rules.

While Novartis is not new to Asia, the Swiss-based company is ramping up efforts to penetrate further into the burgeoning pharmaceutical market by coming up with ingenious ways to cultivate trust and rapport.

Taiwan's Bureau of National Health Insurance (BNHI) has issued its fifth round of price adjustments for prescription medicine; a cut that represents a compromise from earlier plans. The government's initial proposal was to lower prices of 562 pharmaceutical products.